Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.52 |
| ▸ | HPGD | P15428 | 5/20 | 0.52 |
| ▸ | HMGB1 | P09429 | 2/20 | 0.52 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.52 |
| ▸ | ESR1 | P03372 | 1/20 | 0.52 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.52 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | GGT1 | P19440 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phthalic Acid SCHEMBL27946592 | 0.98 | ALDH1A1 (0.52) | ALDH1A1ALOX15KDM4EHSD17B10HPGD | |
| Phthalic Acid SCHEMBL28113690 | 0.98 | ALDH1A1 (0.52) | ALDH1A1ALOX15KDM4EHSD17B10HPGD | |
| Phthalic Acid SCHEMBL28120443 | 0.98 | ALDH1A1 (0.52) | ALDH1A1ALOX15KDM4EHSD17B10HPGD | |
| SCHEMBL5535925 | 0.93 | ALDH1A1 (0.47) | ALDH1A1ALOX15KDM4EHSD17B10HPGD | |
| SCHEMBL4372406 | 0.90 | ALDH1A1 (0.44) | ALDH1A1ALOX15KDM4EHSD17B10HPGD | |
| Toluic Acid SCHEMBL27660801 | 0.90 | ALDH1A1 (0.50) | ALDH1A1ALOX15KDM4EHSD17B10HPGD | |
| SCHEMBL27553780 | 0.88 | ALDH1A1 (0.61) | ALDH1A1ALOX15KDM4EHSD17B10HPGD | |
| Anthranilic Acid SCHEMBL28763510 | 0.88 | HSD17B10 (0.46) | ALDH1A1ALOX15KDM4EHSD17B10HPGD | |
| SCHEMBL27493128 | 0.88 | KDM4E (0.45) | ALDH1A1ALOX15KDM4EHSD17B10HPGD | |
| SCHEMBL9137573 | 0.87 | POLB (0.62) | ALDH1A1ALOX15KDM4EHSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3026 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3368029-B1 | EFLORNITHINE AND SULINDAC, FIXED DOSE COMBINATION FORMULATION | USWM LLC (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4722690-A1 | GREASE EVAPORATION AMOUNT PREDICTION METHOD, PREDICTION DEVICE, AND PROGRAM | NSK LTD. (JP) | 2026-04-08 | — | — | EP | claimed |
| EP-4722504-A1 | METHOD FOR CALCULATING EVAPORATION AMOUNT OF LUBRICANT, CALCULATION DEVICE, AND PROGRAM | NSK LTD. (JP) | 2026-04-08 | — | — | EP | claimed |
| EP-4007500-B1 | PREPARATION COMPRISING OMEGA-3 FATTY ACID SALTS AND EXTRACTS OF GUM RESINS FROM BOSWELLIA SPECIES | EVONIK OPERATIONS GMBH (DE) | 2026-03-25 | — | — | EP | claimed |
| EP-3972581-B1 | PREBIOTIC COMPOSITIONS | EVONIK OPERATIONS GMBH (DE) | 2026-03-25 | — | — | EP | claimed |
| EP-4687850-A1 | ORAL DRUG DOSAGE FORMS FOR COLON DELIVERY AND METHODS OF USE AND MAKING THEREOF | Triastek, Inc. (CN) | 2026-02-11 | — | — | EP | claimed |
| EP-3801493-B1 | SYSTEM FOR MOLDING AND COATING OF PHARMACEUTICAL TABLETS | CONTINUUS PHARMACEUTICALS INC (US) | 2025-12-03 | — | — | EP | claimed |
| US-20250352543-A1 | NANOCRYSTALLINE PREPARATION OF ROCK2 INHIBITOR AND PREPARATION METHOD THEREFOR | BEIJING TIDE PHARMACEUTICAL CO LTD (CN) | 2025-11-20 | — | — | US | claimed |
| US-20250339432-A1 | QUINAZOLINONE COMPOUND AS BRAF INHIBITOR FOR THE TREATMENT OF ADVANCED SOLID CANCER OR METASTASES | HOFFMANN-LA ROCHE INC. (US) | 2025-11-06 | — | — | US | claimed |
| EP-3856147-B1 | METHODS AND PROBIOTIC COMPOSITIONS FOR THE TREATMENT OF BONE DISORDERS | RES FOUND DEV (US) | 2025-09-17 | — | — | EP | claimed |
| US-20020019365-A1 | Pharmaceutical compositions of 2'-deoxy-2'-(fluoromethylene)cytidine | CHIRON CORPORATION | 2002-02-14 | — | — | US | claimed |
| WO-2001091731-A1 | PHARMACEUTICAL COMPOSITIONS OF 2'-DEOXY-2'-(FLUOROMETHYLENE)CYTIDINE | MATRIX PHARMACEUTICAL, INC. (US) | 2001-12-06 | — | — | WO | claimed |
| EP-1098634-A2 | BIOENHANCED FORMULATIONS COMPRISING EPROSARTAN IN ORAL SOLID DOSAGE FORM | SmithKline Beecham Corporation (US) | 2001-05-16 | — | — | EP | claimed |
| US-6113893-A | SOLVENT, ALCOHOL, ALKALI WITH VINYL ACETATE-CROTONIC ACID COPOLYMER OR POLYVINYL ACETATE PHTHALATE AND PLASTICIZERS | PFIZER INC. (US) | 2000-09-05 | — | — | US | claimed |
| WO-2000048578-A1 | COMPOUNDS FOR CARDIOVASCULAR TREATMENT COMPRISING MULTI-VITAMIN AND ANTI-PLATELET AGGREGATING AGENTS AND METHODS FOR MAKING AND USING THE SAME | HEIBEL RICHARD (US) | 2000-08-24 | — | — | WO | claimed |
| WO-2000004862-A2 | BIOENHANCED FORMULATIONS COMPRISING EPROSARTAN IN ORAL SOLID DOSAGE FORM | SMITHKLINE BEECHAM CORPORATION (US) | 2000-02-03 | — | — | WO | claimed |
| US-5710190-A | Soy protein-based thermoplastic composition for foamed articles | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 1998-01-20 | — | — | US | claimed |
| WO-1994013737-A1 | CEREAL GRAIN-BASED BIODEGRADABLE THERMOPLASTIC COMPOSITIONS | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 1994-06-23 | — | — | WO | claimed |
| US-5320669-A | Pretreatment with solvent; crosslinking | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 1994-06-14 | — | — | US | claimed |
| EP-0413120-A2 | Aspirin granules with gastroprotectant coating | STERLING WINTHROP INC. (US) | 1991-02-20 | — | — | EP | claimed |